Tech Investing Pioneer Sees This Lucrative Industry Going Mainstream in a Hurry

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Cannabis Profits Daily. If you have any questions or would like to change free your email settings, please reference the contact information at the bottom of this email. [Cannabis Profits Daily] Saturday, January 5, 2018 Tech Investing Pioneer Sees This Lucrative Industry Going Mainstream in a Hurry By Michael A. Robinson (Editor's Note: When we started the National Institute for Cannabis Investors, we worked diligently to ensure we had the best advisory board in the business. As such, we know you want to hear directly from these experts. Today, we're lucky and honored to have Founding Advisory Board Member Michael Robinson - one of the top tech investors in the world - giving his take on the cannabis industry right now). For the year ahead in cannabis, I think we will see a lot of activity - more IPOs, more investments in the space by larger corporations, etc. As of right now, there are [more than double the number of cannabis stocks]( that we saw in 2017. And remember, not all of the action is taking place up in Canada. Tilray Inc. had a successful IPO just months ago on the Nasdaq. It turned out to be one of the top performing stocks in the market last year. That kind of success will no doubt please senior leaders at privately held cannabis firms. We should see more cannabis IPOs by U.S.-based companies or by Canadian companies looking to uplist onto the major, U.S.-based exchanges in 2019. Besides Tilray, we already have Cronos Group on the Nasdaq as well as Aurora Cannabis, Aphria Inc., and Canopy Growth Corp. on the New York Stock Exchange. Big business also is likely to continue the pace of investments we saw last year, again mostly with Canadian firms because that nation granted full legal status in October. But 2019 could mark [a move toward U.S.-based cannabis investments]( by mainstream firms. That's because with the recent passage of the 2018 Farm Bill, hemp was removed from the U.S. Controlled Substances Act. Sharp analysts know that it was the biggest change in U.S. drug law in roughly 50 years. And I expect to see another bipartisan push to revamp U.S. marijuana laws. As 2018 drew to a close, the STATES Act that would allow states to pass their own marijuana laws and regulatory frameworks had [strong bipartisan support]( in the Senate. And Rep. Nancy Pelosi (D-CA) becoming Speaker of the House this week will not hurt chances of the STATES Act getting through Congress. Pelosi was out in front of the pack back in 2016 when she announced she would vote for California's Proposition 64 to legalize recreational use there. Now, California went fully legal a year ago but got off to a rough start. Established businesses complained of excessive rules and regulations, such as how products are placed in child-proof packaging. The state also suffered from a lack of testing labs when new rules took effect on July 1. After that, sellers had to have their products tested by a licensed lab even though fewer than three dozen existed in a state with a population of more than 35 million residents. But in the last several weeks, the state started to put forth efforts to bring badly needed clarity to this market, one that accounted for half of all legal cannabis sales in the U.S. even before recreational use was added. Add it all up, and you can see that 2019 will be a great year for the cannabis sector and investors as this area increases its [mainstream reach and appeal](. Cheers, and good investing, Michael A. Robinson Founding Advisory Board Member, National Institute for Cannabis Investors P.S.: Our Cannabis Investor's Report members can see 2019 prediction for several other members of the Institute's Founding Advisory Board in the latest edition of the member-only [Monthly Investment Package](. Just click [here](. This IPO Explosion Could Mint a New Generation of Millionaires As we speak, an unprecedented flood of cannabis IPOs is barreling towards us. We're talking about seeing as many as [42 millionaire-making IPOs hit in the next 90 days]( - four could go as early as January 31. And when it happens, it could create [the next round of marijuana millionaires](. And we want you to have an opportunity to be one of them. Just [click here]( to learn how you can get in on this little-understood investing phenomenon. [Get Ready: A $12 Billion Tidal Wave of Wealth Could Be Headed Our Way]( Cannabis IPOs are where the real action is at - where investors have the opportunity to make the biggest returns off this exploding new industry. In fact, we're projecting AT LEAST 1,000% windfalls if you strike early with these four recommendations. [Click here to learn how you can get in on]([this little-understood investing phenomenon](. [Critical: It's time to act on what could be the biggest IPO in marijuana history]( Recently, our team of pot stock analysts sent out [an important alert]( for a small company that just completed their long-awaited IPO. But if you missed the boat on this the first time around, you have [a rare second chance]( to lock in a ground-floor opportunity in one of tomorrow's biggest household names. This could easily [become the next 1,000% winner]( - so I recommend you move fast. [Click here to learn more](. [This could change everything for America's most misunderstood industry]( We just brought together former Speaker of the House John Boehner and the most powerful people in the cannabis world - and they revealed [an uncensored, highly controversial prediction]( that could help you make a fortune. If you missed seeing this historic event LIVE, [click here for a special rebroadcast](. --------------------------------------------------------------- You are receiving this e-mail at {EMAIL}, as a part of your subscription. Remove your email from this list: [Unsubscribe]( © 2019 The National Institute for Cannabis Investors All Rights Reserved The National Institute for Cannabis Investors | 1125 N Charles Street | Baltimore, MD 21201 Toll Free: 866.260.0361; International: 410.777.8270 [Contact Customer Service](mailto:support@nicinvestors.com?subject=Cannabis%20Profits%20Daily%20Question) Website: []( Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This information may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The National Institute for Cannabis Investors, 1125 N Charles Street, Baltimore, MD 21201. [Privacy Policy]( | [Terms & Conditions](